Scarica l'app Stockscreener
6.86
0.88%
0.06
Dopo l'orario di chiusura:
6.85
-0.01
-0.15%
Lifeward Ltd Borsa (LFWD) Ultime notizie
LFWD Earnings History & Surprises | EPS & Revenue Results | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - The Globe and Mail
Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - Investing.com South Africa
Lifeward regains Nasdaq compliance after audit committee appointments - Investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - Stock Titan
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - Stock Titan
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - Stock Titan
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - Stock Titan
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Lifeward (LFWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - Stock Titan
Lifeward adds biotech drug-delivery tech and taps up to $47M - stocktitan.net
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward Successfully Closes on Strategic Partnership with Oramed - Bitget
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - MarketScreener
If You Invested $1,000 in Lifeward Ltd (LFWD) - Stock Titan
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - tradingview.com
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - GuruFocus
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):